# Owner Mode — Long-Term Partnership Report

**Date:** 2026-06-20
**Branch:** claude/cool-ptolemy-dxrpm7
**Commit:** 116f1bd8
**Question:** Does the system create recurring value after the first diagnosis/action/outcome cycle?

---

## 1. What the System Delivers in Each Cycle

### Cycle structure (Phases 29–35)
Each completed intervention cycle produces:

1. **Phase 29:** A classified learning candidate — a structured record of what was attempted, what the evidence said, and what the outcome was, with a deterministic eligibility status.
2. **Phase 30:** A human review — a documented decision by a named reviewer with a decision (APPROVED/REJECTED/DEFERRED) and notes.
3. **Phase 31:** An admission or rejection record — a permanent record of whether the candidate was accepted into the learning corpus.
4. **Phase 33:** A regression result — a documented verification that the candidate doesn't regress existing performance.
5. **Phase 34:** A rollout event — documented staged deployment with audit trail.
6. **Phase 35:** A harm event record (if harm occurs) — documented cause-and-effect with severity and mitigation status.
7. **Phase 35:** An attribution review — documented human judgment of whether the intervention caused the harm.

### What accumulates across cycles
- A workspace-scoped corpus of admitted candidates with verified outcomes
- A workspace-scoped corpus of rejected candidates with documented rejection reasons
- A complete audit trail of every decision and its actor
- A harm event history with mitigation records and attribution verdicts

---

## 2. Recurring Value Mechanisms

### 2a. Institutional memory
Every admitted candidate stores:
- `sourceRecommendationId` — which recommendation led here
- `sourceOwnerDecisionId` — which owner decision triggered the action
- `sourceActionId` — which action was taken
- `sourceOutcomeId` — which outcome was measured
- `evidenceSummary` — what the evidence said

This creates a traceable chain from decision to outcome. In repeated cycles, the system accumulates a verified history of what interventions produced real verified outcomes in this workspace's specific business context.

### 2b. Rejection corpus
Rejected candidates with documented `rejectionCode` and `rejectionReason` provide a record of what was tried and rejected and why. This prevents re-proposing the same interventions that were already rejected for documented reasons.

### 2c. Harm event corpus
Each harm event with `harmType`, `severity`, `harmDescription`, and eventual `mitigatedAt` + attribution verdict produces:
- A record of what caused harm
- A record of whether the intervention was causal
- A documented mitigation approach

In subsequent cycles, this can inform which intervention patterns carry harm risk in this business context.

### 2d. Governance cadence
The 30-day outcome window (HIGH-3) enforces a minimum observation period before any learning signal is admitted. This prevents short-term noise from polluting the learning corpus. Each cycle's outcome is validated after a meaningful observation window.

---

## 3. What Long-Term Partnership Requires

### Requirements met
- ✅ Workspace isolation: each workspace accumulates its own history; no cross-contamination
- ✅ Audit trail: every mutation is recorded with actor and timestamp
- ✅ Non-repudiation: admission records are immutable (DB unique constraint + no update path)
- ✅ Harm tracking: harm events are permanent; cannot be deleted or suppressed
- ✅ Attribution: human review of causation is documented per harm event

### Requirements not yet met

1. **Reassessment trigger:** There is no automated trigger to restart a learning cycle when a harm event is attributed. The system records attribution verdicts but does not initiate a reassessment of the business condition or intervention mode when a CRITICAL harm with verdict=ATTRIBUTED is detected. This is a governance gap: a business owner could have a candidate rolled out, experience attributed harm, and the system does not proactively flag that the business condition should be re-evaluated.

2. **Eligibility status immutability at the business rule level:** `promotionLocked=true` is stored but not enforced. If a business decision is made to lock a candidate from promotion, the lock has no mechanical effect.

3. **No aggregation layer:** The system records individual cycles but provides no service-layer aggregation (e.g., "what is the proportion of admitted candidates that later generated harm events?"). Long-term partnership value from pattern recognition across cycles is not yet automated.

4. **No rate limiting on admission endpoint:** A high-volume submission of candidates could flood the learning corpus. The system has no rate limiting. For single-workspace internal use this is acceptable; for multi-tenant production this is a gap.

---

## 4. Evaluation

| Dimension | Status | Notes |
|-----------|--------|-------|
| Institutional memory | ✅ DELIVERS | Each cycle produces traceable records |
| Rejection corpus | ✅ DELIVERS | Documented rejection reasons prevent re-proposals |
| Harm history | ✅ DELIVERS | Harm events permanent, attribution documented |
| Audit trail | ✅ DELIVERS | Complete, workspace-scoped, non-repudiable |
| Governance enforcement | ✅ DELIVERS | 30-day window, review gate, CRITICAL harm blocks |
| Reassessment trigger | ❌ NOT IMPLEMENTED | No automated re-evaluation after attributed harm |
| Aggregation / analytics | ❌ NOT IMPLEMENTED | No pattern recognition across cycles |
| promotionLocked enforcement | ❌ NOT ENFORCED | Field stored but not checked |
| Rate limiting | ❌ NOT IMPLEMENTED | Acceptable for internal use |

---

## 5. Conclusion

The system creates real and compounding recurring value across multiple intervention cycles:
- Each cycle adds to the workspace's verified learning corpus
- Each harm event + attribution review adds to the workspace's risk history
- The audit trail provides non-repudiable institutional memory

The system is **fit for long-term partnership use at internal/business-owner scale**. It is not yet fit for public SaaS because it lacks aggregation, reassessment automation, and rate limiting.
